Evercore ISI Initiates Coverage on Allscripts Healthcare Solutions (MDRX)

Lloyd Doyle
January 21, 2018

Therefore 100% are positive. Inphi has $60 highest and $26 lowest target. Sell-side firms, on a consensus basis have a $15.84 price target on the name and a 2.20 recommendation, according to First Call. SunTrust Banks downgraded shares of Allscripts Healthcare Solutions from a "buy" rating to a "hold" rating in a report on Tuesday. The rating was maintained by TH Capital with "Buy" on Thursday, December 10. The company was upgraded on Monday, August 24 by Argus Research. The company was maintained on Wednesday, August 5 by Topeka Capital Markets. The company was maintained on Monday, September 11 by Jefferies. The firm has "Hold" rating given on Tuesday, October 17 by DA Davidson. (NASDAQ:MDRX) on Friday, October 6 with "Buy" rating. Commonwealth Of Pennsylvania Public School Empls Retrmt System holds 0.02% of its portfolio in Alleghany Corporation (NYSE:Y) for 2,252 shares. In looking at volatility levels, the shares saw weekly volatility of 2.44% and 2.40% over the past month. Sterling Capital Management LLC grew its stake in shares of Allscripts Healthcare Solutions by 5.4% during the second quarter. Natl Bank Of America De has 0% invested in Allscripts Healthcare Solutions, Inc.

Allscripts Healthcare Solutions (NASDAQ:MDRX) traded up $0.15 during mid-day trading on Thursday, hitting $15.24. The stock had a trading volume of 1,401,766 shares, compared to its average volume of 2,270,000. (NASDAQ:MDRX) has declined 8.32% since January 19, 2017 and is downtrending. It has underperformed by 16.70% the S&P500. The company has market cap of $1.51 billion. It now has negative earnings. Insiders own 0.75% of the company's stock. Poulton Richard J. sold $203,433 worth of Allscripts Healthcare Solutions, Inc. Torten Ron had sold 179 shares worth $6,786 on Wednesday, January 3. North Star Corp invested in 6 shares or 0% of the stock. Diebold Nixdorf, Incorporated earnings have declined with an annualized rate of -25.8% over the last 5 years. MDRX's profit will be $23.48 million for 29.02 P/E if the $0.13 EPS becomes a reality. The software maker reported $0.12 earnings per share for the quarter, meeting the Thomson Reuters' consensus estimate of $0.12.

Investors sentiment increased to 1.14 in Q3 2017. Its up 0.22, from 0.92 in 2017Q2. It fall, as 29 investors sold Inphi Corporation shares while 60 reduced holdings. Texas-based Stephens Group Lc has invested 0.19% in Inphi Corporation (NYSE:IPHI). State Bank Of Mellon Corporation reported 0.01% of its portfolio in Allscripts Healthcare Solutions, Inc. Gilder Gagnon Howe And Lc reported 111,140 shares. (NASDAQ:MDRX). Sentinel Asset Mgmt invested in 0.24% or 716,320 shares. Deutsche Bancorporation Ag stated it has 1.39M shares or 0.01% of all its holdings. Sumitomo Mitsui Asset, Japan-based fund reported 1,063 shares. The firm has a market cap of $2,780.00, a price-to-earnings ratio of -13.14, a P/E/G ratio of 2.13 and a beta of 1.32. 3,689 were reported by Ameritas Partners Inc. Bancshares Of Montreal Can holds 799,973 shares. Legal General Group Plc invested in 0.04% or 98,338 shares. Diversified Trust Communication accumulated 48,445 shares. 195.75 million shares or 0.88% less from 197.48 million shares in 2017Q2 were reported.

The stock decreased 0.50% or $0.23 during the last trading session, reaching $46.22. About 50,759 shares traded. Alleghany Corporation (NYSE:Y) has risen 7.94% since January 20, 2017 and is uptrending. It has outperformed by 21.64% the S&P500.

Stock analysts at Evercore ISI started coverage on shares of Allscripts Healthcare Solutions (NASDAQ:MDRX) in a report issued on Thursday.

The 18 analysts offering 12-month price forecasts for Allscripts Healthcare Solutions Inc have a median target of 16.25, with a high estimate of 19.00 and a low estimate of 12.00. Zacks Investment Research downgraded shares of Allscripts Healthcare Solutions from a "hold" rating to a "sell" rating in a report on Friday, January 12th. Morgan Stanley stated it has 0.01% of its portfolio in Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) was sold by Black Paul. The company was reinitiated on Friday, October 28 by JP Morgan. The rating was upgraded by Leerink Swann on Tuesday, August 23 to "Outperform".


Among 2 analysts covering Alleghany (NYSE:Y), 2 have Buy rating, 0 Sell and 0 Hold. (NASDAQ:MDRX) on Thursday, June 22 with "Buy" rating. Cantor Fitzgerald reiterated a "buy" rating and issued a $17.00 target price on shares of Allscripts Healthcare Solutions in a report on Monday, January 8th. The rating was maintained by RBC Capital Markets with "Sector Perform" on Wednesday, August 5.

Since September 14, 2017, it had 0 buys, and 6 selling transactions for $974,699 activity. $67,607 worth of Allscripts Healthcare Solutions, Inc. The company's stock has grown by 71.87 percent in the past 5 years. Systematic Financial Management LP grew its stake in Allscripts Healthcare Solutions by 1,215.3% in the third quarter. (NASDAQ:MDRX). 16,927 are held by Fdx Advsrs.

Allscripts Healthcare Solutions, Inc. offers clinical software, services, information and connectivity solutions that enable physicians and healthcare providers to deliver patients safety and clinical outcomes in the US. The company has market cap of $2.70 billion. The Company provides intuitive clinical and business solutions including Electronic Health Records, practice management, revenue cycle management, document management, electronic prescribing, clinical trials and services for small to mid-sized practices.

After the recent decrease, investors may also look to see if the stock has entered oversold territory and could possibly ripe for a reversal. The company has a quick ratio of 0.98, a current ratio of 0.98 and a debt-to-equity ratio of 1.20. The stock of Allscripts Healthcare Solutions, Inc.

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the stock. (NASDAQ:MDRX). Panagora Asset Mgmt invested 0% in Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) shares were sold by Farley Brian. Cantab Capital Llp reported 82,975 shares. 20,840 were reported by Tcw Group Inc Inc. It also reduced Ishs U S Home Constr Etf (ITB) stake by 19,072 shares and now owns 1.03 million shares. Aspen Invest Management accumulated 19,735 shares or 0.21% of the stock. First Quadrant Ltd Partnership Ca has 62,300 shares for 0.02% of their portfolio. Swiss Savings Bank owns 291,400 shares for 0% of their portfolio. The France-based Axa has invested 0.02% in Allscripts Healthcare Solutions, Inc. State Of New Jersey Common Pension Fund D holds 0% or 70,000 shares. Vanguard Group Inc Incorporated invested in 14.97M shares.

Other reports by Iphone Fresh

Discuss This Article

FOLLOW OUR NEWSPAPER